SEC Form 4 · accession 0001181431-15-003283
BG Medicine, Inc. · BGMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul R Sohmer
Officer — President & CEO · Director
Period of report
Feb 20, 2015
Accepted (ET)
Feb 24, 2015 · 6:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001407038
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.8201 | Feb 20, 2015 | A | 200,000 | A | — | Feb 20, 2025 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1The option vests as to 25% of the shares on February 20, 2016 and vests as to an additional 6.25% of the shares per quarter thereafter until February 20, 2019.